Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies
02 févr. 2016 08h00 HE
|
AbCellera
JERUSALEM and VANCOUVER, British Columbia, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and AbCellera have entered into a collaborative research...